英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
lanthanoid查看　lanthanoid　在百度字典中的解释百度英翻中〔查看〕
lanthanoid查看　lanthanoid　在Google字典中的解释Google英翻中〔查看〕
lanthanoid查看　lanthanoid　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Treating Squamous Cell Carcinoma | Squamous Cell Cancer . . .
    Treating advanced squamous cell cancers Different types of treatments might be used for SCCs that have spread beyond the skin Lymph node dissection: Removing regional (nearby) lymph nodes might be recommended for some SCCs that are very large or have grown deeply into the skin, as well as if the lymph nodes feel enlarged and or hard
  • Cemiplimab-rwlc - NCI - National Cancer Institute
    FDA label information for this drug is available at DailyMed Use in Cancer Cemiplimab-rwlc is approved to treat adults with: Basal cell carcinoma (BCC) (a type of skin cancer) It is used in patients whose cancer has spread after treatment with hedgehog pathway inhibitor therapy or who cannot receive hedgehog pathway inhibitor therapy Cutaneous squamous cell carcinoma (a type of skin cancer
  • LIBTAYO (cemiplimab-rwlc) Label - Food and Drug Administration
    LIBTAYO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation (1)
  • LIBTAYO® (cemiplimab-rwlc) | Official HCP Website
    LIBTAYO® (cemiplimab-rwlc) is a prescription medicine indicated for the treatment of adult patients with advanced NSCLC, CSCC, BCC, and as an adjuvant treatment for high-risk CSCC See Important Safety full Prescribing Information
  • Cemiplimab-rwlc (Libtayo®) - OncoLink
    About Cemiplimab-rwlc (Libtayo®) The immune system works by creating antibodies, which are proteins that attach to antigens found on the surface of a cell The antibody “calls” the immune system to attack the cell it is attached to, resulting in the immune system killing the cell Monoclonal antibodies are created in a lab to attach to the antigens found on specific types of cancer cells
  • Libtayo (cemiplimab) vs Krazati (adagrasib) - Everyone. org
    Libtayo (cemiplimab) vs Krazati (adagrasib) Libtayo (cemiplimab) and Krazati (adagrasib) are both used in the treatment of certain types of cancer, but they have different mechanisms of action and indications
  • LIBTAYO® Medication Guide | Regeneron
    LIBTAYO® (Lib-TIE-oh) (cemiplimab-rwlc) injection What is the most important information I should know about LIBTAYO? LIBTAYO is a medicine that may treat certain types of cancers by working with your immune system LIBTAYO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work
  • Libtayo (Cemiplimab-rwlc Injection): Side Effects, Uses . . .
    Drug Summary What Is Libtayo? Libtayo (cemiplimab -rwlc) is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation What Are Side Effects of Libtayo?
  • Libtayo (cemiplimab-rwlc) FDA Approval History - Drugs. com
    Libtayo (cemiplimab-rwlc) is a programmed death receptor-1 (PD-1) blocking antibody for the treatment of cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and non-small cell lung cancer (NSCLC)





中文字典-英文字典  2005-2009